Nightingale Health's Remote Health Check becomes part of Coronaria's new weight management service in Finland

Nightingale Health Plc | Press Release | September 22, 2026 at 07:20:00 EEST

Nightingale Health and Coronaria Kuntoutuspalvelut have agreed on the use of Nightingale Health's Remote Health Check in Coronaria's new weight management service. The test is taken from a finger-prick blood sample that the customer collects themselves, and it detects the risks for multiple chronic diseases from a single sample. Coronaria's healthcare professionals use the results to assess the customer's health before the weight management service begins and to follow the health effects of the service at its end.

Under the agreement, Nightingale Health analyses the finger-prick blood samples of Coronaria's customers and delivers the results to Coronaria. From a single blood sample, the Remote Health Check produces a 10-year risk estimate for five chronic diseases: heart attack, ischemic stroke, type 2 diabetes, chronic kidney disease, and fatty liver disease. At the same time, it measures a broad set of blood values, including lipids, fatty acids, amino acids, sugar metabolism, and chronic inflammation. The first test is taken before the weight management service begins, giving the customer and Coronaria's professionals an objective picture of the starting point. A repeat test after the service shows how the customer's disease risks and blood values have changed.

The weight management service launched by Coronaria Kuntoutuspalvelut is an evidence-based 12-month care pathway that combines medical services, medication where needed, monitoring, digital support to keep the customer motivated, and the support of health professionals such as a psychotherapist or a physiotherapist. The Remote Health Check is part of this whole: it is used to assess the customer's starting point and to follow the effects of the treatment on their health.

"In weight management, our goal is lasting change, not just weight loss. The Remote Health Check gives the customer and the care team an objective picture of the customer's health already before the service begins, and the repeat test shows how the disease risks have changed when the service has ended. It makes the change visible to the customer and supports motivation throughout the care pathway," says Arto Lamberg, CEO of Coronaria Kuntoutuspalvelut Oy.

"The ultimate goal of weight management is that a person stays healthy. That is why the effect of treatment should also be measured in disease risks, not only in weight. The Remote Health Check makes this possible without a laboratory visit: the customer takes the sample themselves, and the same test repeated shows which way the risks are moving," says Teemu Suna, CEO and Founder of Nightingale Health.

"Weight management services are a natural use for the Remote Health Check. With Coronaria, the test becomes part of a service where treatment, rehabilitation, and monitoring are delivered together," Teemu Suna continues.

Nightingale Health's technology is in nationwide healthcare use in Finland, where over 250,000 people have already received their results through the Nightingale Health Check, and it is validated in over 1,000 peer-reviewed scientific publications.

About Coronaria
Coronaria is a Finnish healthcare company founded, owned and led by doctors, and part of the Finnish Cor Group. Coronaria is a 100% Finnish company that provides effective, high-quality rehabilitation, oral health and healthcare services throughout Finland. At Coronaria, the customer is supported by a person whose expertise they can trust, and the help the customer receives has a real effect on their own life and the lives of those close to them.

Coronaria Kuntoutuspalvelut Oy is part of Coronaria and one of the largest rehabilitation companies in Finland. Its 1,200 specialists provide rehabilitation that requires specialised expertise. The revenue of Coronaria's rehabilitation services was EUR 94 million in 2025.

Read more about Coronaria's weight management service: https://www.coronaria.fi/painonhallintapalvelu/

For Coronaria enquiries:

Coronaria Kuntoutuspalvelut Oy
Arto Lamberg
CEO
+358 50 400 1108
arto.lamberg[at]coronaria.fi

Jenni-Maria Heikkinen
Director
+358 50 464 8949
jenni-maria.heikkinen[at]coronaria.fi

For further information, please contact
Teemu Suna, CEO
ir@nightingalehealth.com

About Nightingale Health
Chronic diseases cause around 75% of deaths globally and place a growing burden on healthcare systems. The way to address this is preventive healthcare, but until recently the tools to detect disease risks at population scale have not existed. Nightingale Health has built them. The Nightingale Health Check is a blood-based risk detection test that identifies risks for multiple chronic diseases, including cardiovascular disease, type 2 diabetes, kidney disease, and fatty liver disease, from a single blood sample. It is designed to be applied population-wide, so healthcare systems can identify the people who would benefit most from preventive action before disease develops.

Nightingale Health's technology is validated in over 1,000 peer-reviewed scientific publications and is used in many of the world's leading health studies, including the UK Biobank. In Finland, the Nightingale Health Check is in nationwide healthcare use, and over 250,000 people have already received their results. Nightingale Health operates globally with a parent company in Finland and subsidiaries in countries such as Japan, the United States, Singapore, and the United Kingdom, and has customers in more than 34 countries across healthcare and medical research. The company's Series B shares are listed on the Main Market of Nasdaq Helsinki and on the OTCQX International market. Read more: https://nightingalehealth.com/

Image Attachments
Nightingale Health